Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Trevena Inc (TRVN)  
$0.40 0.00 (0.00%) as of 4:30 Mon 4/29


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 7,710,000
Market Cap: 3.08(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.352 - $3.11
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Trevena is a biopharmaceutical company. Co.'s primary product, OLINVYK™ (oliceridine) injection, is an opioid agonist for use in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. Co.'s product candidates include: TRV027, which is an angiotensin II type 1 receptor selective agonist, for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abnormal blood clotting in patients with COVID-19; TRV250, which is a G-protein biased delta-opioid receptor agonist as a compound with a mechanism for the treatment of acute migraine; and TRV045, which is a S1P modulator.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 31,785
Total Sell Value $0 $0 $0 $13,032
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 142
  Page 4 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Moulder Leon O Jr Director   –       •      –    2019-02-01 4 B $1.02 $102,000 I/I 100,000 100,000 2.1     -
   Hamill John P. VP Fin,Princ Fin&Acct Officer   •       –      –    2018-12-06 4 A $0.00 $0 D/D 80,000 80,250     -
   Yoder Robert T Sr. VP, Chief Business Officer   •       –      –    2018-12-06 4 A $0.00 $0 D/D 100,000 100,000     -
   Bourdow Carrie L. President and CEO   •       •      –    2018-12-06 4 A $0.00 $0 D/D 250,000 254,500     -
   Demitrack Mark Sr VP & Chief Medical Officer   •       –      –    2018-12-06 4 A $0.00 $0 D/D 125,000 125,000     -
   Habib Yacoub SVP, Bus Dev & Corp Planning   •       –      –    2018-03-22 4 S $1.76 $8,800 D/D (5,000) 0     -
   Gowen Maxine President & CEO   •       •      –    2017-05-25 4 GA $0.00 $0 I/I 403 195,512     -
   Gowen Maxine President & CEO   •       •      –    2017-05-25 4 GD $0.00 $0 D/D 403 4,000     -
   Gowen Maxine President & CEO   •       •      –    2017-03-16 4 GA $0.00 $0 I/I 60,000 216,500     -
   Gowen Maxine President & CEO   •       •      –    2017-03-16 4 GD $0.00 $0 D/D 60,000 4,403     -
   Gowen Maxine President & CEO   •       •      –    2017-03-13 4 GA $0.00 $0 I/I 50,000 195,109     -
   Gowen Maxine President & CEO   •       •      –    2017-03-13 4 GD $0.00 $0 D/D 50,000 64,403     -
   Gowen Maxine President & CEO   •       •      –    2017-02-23 4 OE $0.68 $75,295 D/D 110,403 126,903     -
   Lark Michael W. Sr. VP, Research & CSO   •       –      –    2017-02-10 4 AS $8.00 $189,592 D/D (23,699) 74,761     -
   Lark Michael W. Sr. VP, Research & CSO   •       –      –    2017-02-10 4 OE $0.68 $8,740 D/D 12,815 98,460     -
   Gowen Maxine President & CEO   •       •      –    2017-01-23 4 GA $0.00 $0 I/I 12,500 145,109     -
   Gowen Maxine President & CEO   •       •      –    2017-01-23 4 GD $0.00 $0 D/D 12,500 114,403     -
   Gowen Maxine President & CEO   •       •      –    2017-01-06 4 GA $0.00 $0 I/I 150,000 150,000     -
   Gowen Maxine President & CEO   •       •      –    2017-01-06 4 GD $0.00 $0 I/I 150,000 4,000     -
   Bourdow Carrie L. SVP, Chief Commercial Officer   •       –      –    2016-11-09 4 B $4.34 $17,360 D/D 4,000 4,500 2.74     -
   Gowen Maxine President & CEO   •       •      –    2016-11-07 4 B $4.10 $51,250 D/D 12,500 16,500 2.81     -
   Habib Yacoub SVP, Bus Dev & Corp Planning   •       –      –    2016-11-07 4 B $4.12 $20,600 D/D 5,000 5,000 2.74     -
   Gowen Maxine President & CEO   •       •      –    2016-10-20 4 GA $0.00 $0 I/I 14,084 139,109     -
   Gowen Maxine President & CEO   •       •      –    2016-10-20 4 GD $0.00 $0 D/D 14,084 4,000     -
   Gowen Maxine President & CEO   •       •      –    2016-10-17 4 GA $0.00 $0 I/I 145,025 144,000     -

  142 Records found
  1  2  3  4  5  6   
  Page 4 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed